Japan Precision Medicine Market Size & Outlook, 2023-2030

The precision medicine market in Japan is expected to reach a projected revenue of US$ 20,972.8 million by 2030. A compound annual growth rate of 22.7% is expected of Japan precision medicine market from 2024 to 2030.
Revenue, 2023 (US$M)
$4,997.0
Forecast, 2030 (US$M)
$20,972.8
CAGR, 2024 - 2030
22.7%
Report Coverage
Japan

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Japan precision medicine market, 2018-2030 (US$M)

Japan precision medicine market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Japan precision medicine market highlights

  • The Japan precision medicine market generated a revenue of USD 4,997.0 million in 2023 and is expected to reach USD 20,972.8 million by 2030.
  • The Japan market is expected to grow at a CAGR of 22.7% from 2024 to 2030.
  • In terms of segment, therapeutics was the largest revenue generating application in 2023.
  • Diagnostics is the most lucrative application segment registering the fastest growth during the forecast period.

Precision medicine market data book summary

Market revenue in 2023USD 4,997.0 million
Market revenue in 2030USD 20,972.8 million
Growth rate22.7% (CAGR from 2024 to 2030)
Largest segmentTherapeutics
Fastest growing segmentDiagnostics
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDiagnostics, Therapeutics
Key market players worldwideRoche, Siemens Healthineers AG ADR, Janssen Pharmaceuticals, Illumina Inc, Quest Diagnostics Inc, 23andMe Holding Co Class A, NeoDiagnostix, International Business Machines Corp, Myriad Genetics Inc, Medtronic PLC, GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Dakota Software, Biogen Inc, Qiagen NV, ImmunityBio Inc Ordinary Shares

Other key industry trends

  • In terms of revenue, Japan accounted for 5.7% of the global precision medicine market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan precision medicine market is projected to lead the regional market in terms of revenue in 2030.
  • Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 20,972.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Precision Medicine Market Companies

Name Profile # Employees HQ Website
ImmunityBio Inc Ordinary Shares View profile 628 3530 John Hopkins Court, San Diego, CA, United States, 92121 https://www.immunitybio.com
NeoDiagnostix View profile 1-10 Rockville, Maryland, United States, North America https://neodiagnostix.com
Janssen Pharmaceuticals View profile 1-10 Titusville, New Jersey, United States, North America https://www.xarelto-us.com
23andMe Holding Co Class A View profile 816 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 https://www.23andme.com
Biogen Inc View profile 7570 225 Binney Street, Cambridge, MA, United States, 02142 https://www.biogen.com
Roche View profile 10001+ Basel, Basel-Stadt, Switzerland, Europe http://www.roche.com
Dakota Software View profile 51-100 Cleveland, Ohio, United States, North America http://dakotasoft.com
Myriad Genetics Inc View profile 2700 320 Wakara Way, Salt Lake City, UT, United States, 84108 https://www.myriad.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Quest Diagnostics Inc View profile 48000 500 Plaza Drive, Secaucus, NJ, United States, 07094 https://www.questdiagnostics.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
International Business Machines Corp View profile 282200 One New Orchard Road, Armonk, NY, United States, 10504 http://www.ibm.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
GE HealthCare Technologies Inc Common Stock View profile 51000 500 West Monroe Street, Chicago, IL, United States, 60661 https://www.gehealthcare.com

Japan precision medicine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to precision medicine market will help companies and investors design strategic landscapes.


Therapeutics was the largest segment with a revenue share of 74.15% in 2023. Horizon Databook has segmented the Japan precision medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.


In Japan, the government has established an Integrated Community Care System that seamlessly combines healthcare, long-term care, housing, and livelihood support services. This system allows the elderly to receive continuous, high-quality care within their local communities rather than in hospitals, reducing healthcare costs & hospital use and improving health outcomes.

Despite challenges, such as the low percentage of cancer patients receiving personalized drugs based on genomic profiling, R&D is expanding. Japan’s collaboration with other Asian countries under the SCRUM-Japan project, led by the National Cancer Center Hospital East, exemplifies this growth.

In September 2022, the Japanese government approved the "Whole Genome Analysis 2022" Action Plan to integrate personalized medicine into routine medical care, with progress being made in addressing related issues. Since the approval of cancer genetic testing in 2019, Japan has been advancing the social implementation of personalized medicine.

Reasons to subscribe to Japan precision medicine market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan precision medicine market databook

  • Our clientele includes a mix of precision medicine market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan precision medicine market , including forecasts for subscribers. This country databook contains high-level insights into Japan precision medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan precision medicine diagnostics therapeutics market size, by application, 2018-2030 (US$M)

Japan Precision Medicine Market Outlook Share, 2023 & 2030 (US$M)

Japan precision medicine diagnostics therapeutics market size, by application, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online